OBJECTIVES: Cardiac resynchronization therapy with biventricular pacemaker (CRT-P) is
considered an effective treatment for heart failure (HF). Adding implantable cardioverter …

Objectives Cardiac resynchronization therapy with a biventricular pacemaker (CRT-P) is an
effective treatment for dyssynchronous heart failure (DHF). Adding an implantable …

Introduction Heart failure (HF) is an unusual heart function that causes reduction in cardiac
or pulmonary output. Cardiac resynchronization therapy (CRT) is a mechanical device that …

Heart failure is a leading contributor to overall morbidity and mortality and, unlike coronary
artery disease, has declining survival rates. 1 At the time of diagnosis, patients have a 1-year …

Aims Cardiac resynchronization therapy (CRT-P) is an effective treatment for patients with
heart failure and cardiac dyssynchrony with moderate or severe symptoms despite …

Objective The objective of this study was to quantify the impact that longer battery life of
cardiac resynchronization therapy defibrillator (CRT-D) devices has on reducing the number …

Cost-effectiveness estimates can help optimize use of available financial resources and this
is especially relevant for implementation of cardiac resynchronization therapy (CRT), given …

Abstract Background In Germany, CRT devices with defibrillator capability (CRT-D) have
become the predominant treatment strategy for patients with heart failure and cardiac …

Cardiac resynchronization therapy (CRT) is a treatment of proven efficacy for selected
patients with heart failure and associated conduction disturbances. The increasing financial …

Aim The aim of the study was to assess the incremental cost-effectiveness ratio (ICER) of
Cardiac Resynchronization Therapy in combination with an Implantable Cardioverter …